Evidence map›Paper›PMID 35789592›Full record

ArticleJournal of diabetes research2022

Long-Term Metabolic Outcomes after Gestational Diabetes Mellitus (GDM): Results from the Odense GDM Follow-Up Study (OGFUS).

Kristine Hovde Jacobsen, Jori Aalders, Katrine Sølling, Marianne Skovsager Andersen, Lena Sønder Snogdal, Maria Hornstrup Christensen, Christina Anne Vinter, Kurt Højlund, Dorte Møller Jensen

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Gestational Diabetes Mellitus and Adverse Maternal and Neonatal Health Outcomes: an Umbrella review of Meta-Analyses.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kristine Hovde JacobsenSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-3808-011X
Jori AaldersSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-7207-8304
Katrine SøllingSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-3695-7344
Marianne Skovsager AndersenDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID https://orcid.org/0000-0002-4603-9504
Lena Sønder SnogdalSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0001-8999-4651
Maria Hornstrup ChristensenSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-4985-4491
Christina Anne VinterSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0001-5084-6053
Kurt HøjlundSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-0891-4224
Dorte Møller JensenSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0002-3298-9824
Steno Diabetes Centers · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To compare metabolic profiles and the long-term risk of metabolic dysfunction between women with previous gestational diabetes mellitus (pGDM) and women without pGDM (non-GDM) matched on age, prepregnancy body mass index (BMI), and parity. Methods: In total, 128 women with pGDM (median follow-up: 7.8 years) and 70 non-GDM controls (median follow-up: 10.0 years) completed a 2 h oral glucose tolerance test (OGTT) with assessment of glucose, C-peptide, insulin, and other metabolic measures. Additionally, anthropometrics, fat mass, and blood pressure were assessed and indices of insulin sensitivity and beta cell function were calculated. Results: The prevalence of type 2 diabetes mellitus (T2DM) was significantly higher in the pGDM group compared to the non-GDM group (26% vs. 0%). For women with pGDM, the prevalence of prediabetes (38%) and the metabolic syndrome (MetS) (59%) were approximately 3-fold higher than in non-GDM women ( Conclusion: Despite similar BMI, women with pGDM had a substantially higher risk of developing T2DM, prediabetes, and the MetS compared to controls. Both beta cell dysfunction and reduced insulin sensitivity seem to contribute to this increased risk.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2Insulin ResistanceMetabolic SyndromePrediabetic StateFemaleFollow-Up StudiesHumansInsulinPregnancyInsulin

Identifiers

PMID35789592
PMCPMC9250439
OpenAlexW4283518624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.